Russell Investments Group, Ltd. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Russell Investments Group, Ltd.

$60.3 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$144.95 - $152.29 $2.76 Million - $2.9 Million	-19,016 Reduced 24.65%	58,141 $8.79 Million
Q2 2022 Jul 29, 2022	SELL	$83.14 - $145.99 $2.62 Million - $4.59 Million	-31,465 Reduced 28.97%	77,157 $11.2 Million
Q1 2022 May 05, 2022	BUY	$110.08 - $142.92 $1.78 Million - $2.31 Million	16,150 Added 17.46%	108,622 $12.9 Million
Q4 2021 Jan 21, 2022	BUY	$99.73 - $148.48 $3.07 Million - $4.57 Million	30,789 Added 49.91%	92,472 $12.7 Million
Q3 2021 Nov 08, 2021	BUY	$98.85 - $138.91 $770,140 - $1.08 Million	7,791 Added 14.46%	61,683 $8.57 Million
Q2 2021 Aug 04, 2021	BUY	$65.78 - $105.02 $1.65 Million - $2.64 Million	25,103 Added 87.2%	53,892 $5.23 Million
Q1 2021 May 10, 2021	SELL	$64.07 - $91.75 $1.1 Million - $1.57 Million	-17,097 Reduced 37.26%	28,789 $1.97 Million
Q4 2020 Feb 08, 2021	SELL	$65.07 - $98.24 $2.91 Million - $4.4 Million	-44,747 Reduced 49.37%	45,886 $3.93 Million
Q3 2020 Nov 09, 2020	BUY	$59.04 - $77.95 $1.01 Million - $1.34 Million	17,182 Added 23.39%	90,633 $5.89 Million
Q2 2020 Aug 05, 2020	BUY	$29.01 - $74.23 $145,920 - $373,376	5,030 Added 7.35%	73,451 $5.37 Million
Q1 2020 May 06, 2020	BUY	$27.51 - $57.29 $839,687 - $1.75 Million	30,523 Added 80.54%	68,421 $2.33 Million
Q4 2019 Jan 29, 2020	BUY	$40.86 - $57.65 $764,368 - $1.08 Million	18,707 Added 97.48%	37,898 $2.06 Million
Q3 2019 Nov 01, 2019	BUY	$37.38 - $49.47 $717,359 - $949,378	19,191 New	19,191 $801,000
Q1 2019 May 13, 2019	SELL	$34.52 - $53.29 $440,302 - $679,713	-12,755 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$29.75 - $42.9 $7,675 - $11,068	258 Added 2.06%	12,755 $472,000
Q3 2018 Oct 26, 2018	SELL	$32.79 - $43.0 $698,623 - $916,158	-21,306 Reduced 63.03%	12,497 $469,000
Q1 2018 May 11, 2018	BUY	$22.49 - $34.56 $760,229 - $1.17 Million	33,803 New	33,803 $871,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account